Earnings Call Transcripts

Access detailed transcripts and key takeaways from company earnings calls

All Earnings Calls

SGRP May 12, 2026

SPAR Group Inc. Q1 2026 Earnings Call - Margin Expansion Driven by Strategic Shift to Recurring Merchandising

SPAR Group is executing a deliberate pivot away from low-margin project-based remodel work toward higher-margin, recurring core merchandising services. This strategic shift is already showing results:...

  • Gross margins expanded to 22.3% in Q1 2026, up from 21.4% in the prior year quarter, driven by a strategic shift toward higher-margin recurring merchandising services.
  • Revenue declined 10.3% year-over-year to $30.5 million, reflecting a deliberate reduction in lower-margin project-based remodel work.
  • Adjusted EBITDA turned positive at $737,000, marking a return to profitability after a period of restructuring and margin compression.
  • +7 more takeaways
EHTH May 12, 2026

eHealth Q1 2026 Earnings Call - eHealth pivots from growth to cash flow with lifetime advisory model

eHealth reported a disciplined first quarter, prioritizing unit economics and cash flow over raw enrollment volume in a disrupted Medicare Advantage market. Revenue fell 22% to $88 million as the comp...

  • Revenue declined 22% year-over-year to $88 million, driven by a deliberate pullback in variable marketing spend to prioritize higher-quality enrollment channels.
  • Adjusted EBITDA of $9 million beat internal expectations, signaling improved operating efficiency despite lower top-line volume.
  • Medicare Lifetime Value to Customer Acquisition Cost (LTV to CAC) ratio improved 17% to 1.4x, reflecting better unit economics and a more disciplined approach to lead generation.
  • +7 more takeaways
MWH May 12, 2026

SOLV Energy Q1 2026 Earnings Call - Backlog Hits $8.2B, Guidance Raised on Margin Outperformance

SOLV Energy delivered a quarter that defied the typical EPC narrative. Revenue surged 66% year-over-year to $677 million, while adjusted EBITDA more than doubled to $93 million. The company raised ful...

  • Revenue surged 66% year-over-year to $677 million, driven by strong project execution and backlog conversion.
  • Adjusted EBITDA jumped 174% year-over-year to $93 million, reflecting significant operating leverage and margin expansion.
  • Full-year 2026 adjusted EBITDA guidance raised to $435-455 million from $400-420 million; adjusted gross profit guidance increased to $610-650 million.
  • +7 more takeaways
ARVN May 12, 2026

Arvinas Q1 2026 Earnings Call - PROTAC Pioneer Secures First Approval, Partners VEPPANU with Rigel, and Shifts Focus to High-Potency Pipeline

Arvinas has crossed the finish line. The company’s Vepdegestrant, now branded VEPPANU, has secured FDA approval as the first-ever PROTAC degrader to reach the market. This is not just a regulatory win...

  • FDA approved Vepdegestrant (VEPPANU) as the first-ever PROTAC degrader for ESR1 mutant, ER+ advanced breast cancer, validating Arvinas’ platform after over a decade of development.
  • Arvinas licensed global rights to VEPPANU to Rigel Pharmaceuticals in a deal with Pfizer, removing commercialization burden and allowing a strategic pivot to early-stage pipeline development.
  • The company maintains a strong balance sheet with $614.9 million in cash and marketable securities, extending its runway into the second half of 2028.
  • +11 more takeaways
LINE May 12, 2026

Lineage Q1 2026 Earnings Call - Stabilization Signals Emerge Amid Supply Overhang

Lineage delivered a better-than-expected first quarter, with adjusted EBITDA rising 3.3% to $314 million and same-store NOI declining just 0.9%. The results highlight a stabilizing core business as th...

  • Adjusted EBITDA rose 3.3% year-over-year to $314 million, outperforming expectations despite flat revenue.
  • Same-store physical occupancy dipped 290 basis points to 76.4%, but economic occupancy remained stable at 82%.
  • Same-store rent, storage, and blast revenue per physical pallet increased 2.2% for the fourth consecutive quarter.
  • +7 more takeaways
DAC May 12, 2026

Danaos Corporation Q1 2026 Earnings Call - Surge in Dry Bulk Spot Rates and Strategic LNG Diversification Amid Geopolitical Disruption

Danaos Corporation reported a sharp rise in adjusted net income for Q1 2026, driven largely by a dramatic improvement in its dry bulk spot market, where time charter equivalent earnings nearly doubled...

  • Adjusted net income rose 8% to $122.5 million, or $6.72 per share, beating Q1 2025 levels as dry bulk spot rates surged.
  • Dry bulk time charter equivalent earnings averaged $24,825 per day in Q1 2026, nearly double the $10,500 per day recorded in Q1 2025, highlighting a dramatic market improvement.
  • Containership revenue backlog stands at $4.1 billion with a 4.2-year average duration, offering 100% coverage for 2026 and 88% for 2027.
  • +7 more takeaways
TONX May 12, 2026

TON Strategy Company Q1 2026 Earnings Call - CEO Transition & Staking Revenue Surge Amid $88M Unrealized Loss

TON Strategy Company reported its first quarter 2026 results under new CEO Kevin Wilson, who took over on May 4th but framed the strategy for the quarter ended March 31st. The company holds 221.9 mill...

  • TON Strategy Company holds 221.9 million Toncoin as of March 31, 2026, with 221.2 million staked, representing 4.29% of the total supply and 26.18% of the staked network.
  • New CEO Kevin Wilson, who officially started May 4th, will focus on long-term per-share value growth, active market communication, and supporting deeper liquidity for Toncoin.
  • The company generated 2.2 million Toncoin in staking rewards during Q1 2026, recognized as $3 million in staking revenue, demonstrating the productivity of its treasury strategy.
  • +7 more takeaways
AMTM May 12, 2026

Amentum Q2 2026 Earnings Call - Record Backlog and Digital Infrastructure Push

Amentum delivered a solid second quarter with revenue of $3.5 billion and adjusted EBITDA of $275 million, driven by strong demand in its accelerating growth markets. The company reported a record bac...

  • Record backlog of nearly $48 billion, up 7% year-over-year, with a book-to-bill ratio of 1.2x indicating strong demand.
  • Revenue of $3.5 billion, reflecting 3% normalized growth, with adjusted EBITDA of $275 million and 7.9% margins.
  • Digital Solutions segment grew 10% year-over-year, driven by critical digital infrastructure and space systems awards.
  • +7 more takeaways
NVST May 12, 2026

Envista Holdings Q1 2026 Earnings Call - Broad-Based Growth and Margin Expansion Drive 50% EPS Jump

Envista Holdings delivered a robust start to 2026 with Q1 core revenue growth of 9.5%, driven by double-digit gains across orthodontics, consumables, and diagnostics, alongside mid-single-digit growth...

  • Envista reported Q1 2026 core revenue growth of 9.5%, with all major business segments delivering positive growth. Orthodontics, consumables, and diagnostics grew double digits, while implants grew mid-single digits excluding China.
  • Adjusted EBITDA increased 25% year-over-year, and EPS jumped 50%, driven by 100 basis points of gross margin expansion and a lower effective tax rate after resolving a legacy intercompany loan.
  • The company announced an incremental $300 million share repurchase authorization, signaling confidence in its cash generation and capital allocation strategy. Q1 free cash flow was negative $16 million, primarily due to increased capital expenditures for new manufacturing facilities.
  • +7 more takeaways
NUWE May 12, 2026

Nuwellis Q1 2026 Earnings Call - Revenue Surges 26% as Pediatric Focus and Strategic Reset Drive Execution

Nuwellis reported a 26% year-over-year revenue increase to $2.4 million in Q1 2026, driven by stronger console and circuit sales. Gross margins improved to 70.1%, reflecting better pricing, product mi...

  • Revenue increased 26% year-over-year to $2.4 million, driven by stronger console and circuit sales.
  • Gross margin improved to 70.1%, up 14% year-over-year, reflecting better pricing, product mix, and contract manufacturing transition.
  • The company completed the acquisition of Rendiatech, adding automated kidney function monitoring to its cardiorenal platform, with a U.S. launch planned for 2027.
  • +7 more takeaways